≪英文≫

Aging potentially reduces CD169 expression in sinus macrophages of pelvic lymph nodes.

Ibe Y, Ozaki Y, Anami T, Yano H, Fujiwara Y, Nishizawa H, Kurahashi R, Motoshima T, Murakami Y, Yatsuda J, Komohara Y, Kamba T.

Med Mol Morphol. 2025 Mar 24. doi: 10.1007/s00795-025-00433-3. Online ahead of print. PMID: 40126633

 

Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.

Takahashi M, Matsushita Y, Kojima T, Osawa T, Sazuka T, Hatakeyama S, Goto K, Numakura K, Yamana K, Kandori S, Fujita K, Ueda K, Tanaka H, Tomida R, Kurahashi T, Bando Y, Kimura T, Nishiyama N, Yamashita S, Taniguchi H, Monji K, Ishiyama R, Kawasaki Y, Kato T, Tatarano S, Masui K, Nakamura E, Kaneko T, Miyake M, Kitano G, Motoshima T, Shiraishi Y, Kira S, Murashima T, Hara H, Matsumura M, Kitamura H, Miyake H, Furukawa J; Japanese Urological Oncology Group.

Clin Genitourin Cancer. 2005 Feb 26:102322. doi: 10.1016/j.clgc.2025.102322. Online ahead of print. PMID: 40118720

 

Impact of Neoadjuvant Chemohormonal Therapy With GnRH Antagonist and Low-Dose Estramustine in Very High-Risk Prostate Cancer Undergoing Robotic Radical Prostatectomy.

Kambe T, Kubota M, Yamasaki T, Kawakita M, Murata S, Hattori Y, Tohi Y, Sekine Y, Kurahashi R, Shimatani K, Sawada A, Negoro H, Saito R, Goto T, Kobayashi T.

Prostate. 2005 Feb 19:e24875. doi: 10.1002/pros.24875. Online ahead of print. PMID: 39972593

 

Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy..

Hara S, Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsubara Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kimura T; Japan Urological Oncology Group.

Int J Urol. 2025 Feb 5. doi: 10.1111/iju.70005. Online ahead of print. PMID: 39907200

 

Enhancing thin slice 3D T2-weighted prostate MRI with super-resolution deep learning reconstruction: Impact on image quality and PI-RADS assessment.

Shiraishi K, Nakaura T, Kobayashi N, Uetani H, Nagayama Y, Kidoh M, Yatsuda J, Kurahashi R, Kamba T, Yamahita Y, Hirai T.

Magn Reson Imaging. 2025;117:110308.

 

Effects of aging on complications following robot-assisted radical prostatectomy.

Koterazawa S, Kubota M, Sumiyoshi T, Saito R, Takaoka N, Hattori Y, Shimizu Y, Kanno T, Soda T, Okada Y, Tsuchihashi K, Sekine Y, Negoro H, Kurahashi R, Shimatani K, Sawada A, Akamatsu S, Goto T, Kobayashi T.

Int J Clin Oncol. 2025;30(2):340-350.

 

The effect of human leukocyte antigen genotype on survival in advanced prostate cancer treated with primary androgen deprivation therapy: the KYUCOG-1401-A study.

Shiota M, Tanegashima T, Tatarano S, Kamoto T, Matsuyama H, Sakai H, Igawa T, Kamba T, Fujimoto N, Yokomizo A, Naito S, Eto M.

Prostate Cancer Prostatic Dis. 2025;28(1):193-201.

 

HIF1α Plays a Crucial Role in the Development of TFE3-Rearranged Renal Cell Carcinoma by Orchestrating a Metabolic Shift Toward Fatty Acid Synthesis.

Nishizawa H, Funasaki S, Ma W, Kubota Y, Watanabe K, Arima Y, Kuroda S, Ito T, Furuya M, Motoshima T, Nishiyama A, Mehanna S, Satou Y, Hasumi H, Jikuya R, Makiyama K, Tamura T, Oike Y, Tanaka Y, Suda T, Schmidt LS, Linehan WM, Baba M, Kamba T.

Genes Cells. 2025;30(1):e13195.

 

Immunohistochemical Analysis of a1-Acid Glycoprotein and Tumor Associated Macrophages in Clear Cell Renal Cell Carcinoma.

Ezaki A, Yano H, Pan C, Fujiwara Y, Anami T, Ibe Y, Ozaki Y, Nishizawa H, Motoshima T, Yatsuda J, Watanabe H, Maruyama T, Takeo T, Kamba T, Komohara Y.

Cancer Genomics Proteomics. 2025;22(1):103-111.

 

≪和文≫